Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer, Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06938880
What this trial is testing

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Not applicableActive Not RecruitingNCT02293954
What this trial is testing

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Who this might be right for
Breast CancerColon CancerExtrahepatic Bile Duct Cancer+9 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Testing effectiveness (Phase 2)WithdrawnNCT04158700
What this trial is testing

LY3200882 and Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Testing effectiveness (Phase 2)Looking for participantsNCT07341737
What this trial is testing

SL-28 for Advanced Solid Tumours

Who this might be right for
Head & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more
Second Life Therapeutics 60
Not applicableStudy completedNCT07224737
What this trial is testing

Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
City of Hope Medical Center 230
Early research (Phase 1)Study completedNCT03652077
What this trial is testing

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Who this might be right for
Cervical CancerGastric CancerStomach Cancer+18 more
Incyte Corporation 40
Early research (Phase 1)Study completedNCT00539383
What this trial is testing

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

Who this might be right for
Advanced Solid Tumors With and Without Brain Metastases
Angiochem Inc 56
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT04374877
What this trial is testing

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorClear Cell Renal Cell CarcinomaHepatocellular Carcinoma+1 more
Coherus Oncology, Inc. 145
Not applicableUnknownNCT05932719
What this trial is testing

Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators

Who this might be right for
Hepatocellular CarcinomaPeritoneal Carcinoma
Hospices Civils de Lyon 4,000
Early research (Phase 1)Temporarily pausedNCT00264472
What this trial is testing

5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

Who this might be right for
Neoplasms
Adherex Technologies, Inc. 60
Early research (Phase 1)Looking for participantsNCT07391670
What this trial is testing

A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab

Who this might be right for
Solid Tumours
AstraZeneca 40
Very early researchNot Yet RecruitingNCT07781852
What this trial is testing

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

Who this might be right for
Bladder CancerGliomaGlioblastoma (GBM)+13 more
Lumina Pharmaceuticals Inc 40
Early research (Phase 1)Study completedNCT02947165
What this trial is testing

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Breast CancerLung CancerHepatocellular Cancer+3 more
Novartis Pharmaceuticals 120
Post-approval studies (Phase 4)Study completedNCT00666978
What this trial is testing

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Lisa Sanderson Cox, PhD 540
Testing effectiveness (Phase 2)WithdrawnNCT05212922
What this trial is testing

Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC

Who this might be right for
HCCNSCLC Stage IIIBNSCLC Stage IV
Eucure (Beijing) Biopharma Co., Ltd
Next Page